Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Pharmacology services47.04M93.78%
Other Translational Oncology Solutions (TOS) revenue3.1M6.18%
Personalized oncology services18K0.04%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States50.16M100.00%